What is a stock summary page? Click here for an overview.
Business Description
ZYUS Life Sciences Corp
NAICS : 325412
SIC : 3741
ISIN : CA9899601095
Compare
Compare
Traded in other countries / regions
ZYUS.CanadaZLSCF.USA IPO Date
2023-08-16Description
ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -8.84 | |||||
| Beneish M-Score | -3.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 1.93 | |||||
| 9-Day RSI | 24.84 | |||||
| 14-Day RSI | 49.01 | |||||
| 3-1 Month Momentum % | -14.29 | |||||
| 6-1 Month Momentum % | -18.92 | |||||
| 12-1 Month Momentum % | -23.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.24 | |||||
| Quick Ratio | 0.11 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 4524.89 | |||||
| Days Sales Outstanding | 480.15 | |||||
| Days Payable | 6364.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 24.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.42 | |||||
| Operating Margin % | -3700 | |||||
| Net Margin % | -8086.95 | |||||
| FCF Margin % | -1697 | |||||
| ROE % | -151.88 | |||||
| ROA % | -82.53 | |||||
| ROIC % | -33.52 | |||||
| ROC (Joel Greenblatt) % | -312.52 | |||||
| ROCE % | -137.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 114.29 | |||||
| PB Ratio | 4 | |||||
| EV-to-EBIT | -1.6 | |||||
| EV-to-EBITDA | -1.73 | |||||
| EV-to-Revenue | 148.41 | |||||
| EV-to-Forward-Revenue | 124.21 | |||||
| EV-to-FCF | -8.79 | |||||
| Earnings Yield (Greenblatt) % | -62.5 | |||||
| FCF Yield % | -12.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZLSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ZYUS Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.333 | ||
| EPS (TTM) ($) | -0.431 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 131911.83 | ||
| 14-Day RSI | 49.01 | ||
| 14-Day ATR ($) | 0.001111 | ||
| 20-Day SMA ($) | 0.6 | ||
| 12-1 Month Momentum % | -23.53 | ||
| 52-Week Range ($) | 0.0005 - 0.81 | ||
| Shares Outstanding (Mil) | 74.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ZYUS Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ZYUS Life Sciences Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ZYUS Life Sciences Corp Frequently Asked Questions
What is ZYUS Life Sciences Corp(ZLSCF)'s stock price today?
The current price of ZLSCF is $0.60. The 52 week high of ZLSCF is $0.81 and 52 week low is $0.00.
When is next earnings date of ZYUS Life Sciences Corp(ZLSCF)?
The next earnings date of ZYUS Life Sciences Corp(ZLSCF) is .
Does ZYUS Life Sciences Corp(ZLSCF) pay dividends? If so, how much?
ZYUS Life Sciences Corp(ZLSCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers